Trials / Completed
CompletedNCT05516927
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
The Sanderson Study: A Diagnostic Case-Control Study for the Development of Multiomics Blood Tests for Cancer Screening in a Real World Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 788 (actual)
- Sponsor
- Freenome Holdings Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
This protocol is a prospective, case-control multi-center diagnostic study to assess the sensitivity and specificity of blood-based screening tests for the early detection of multiple cancers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Freenome Test | Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled. |
Timeline
- Start date
- 2022-09-06
- Primary completion
- 2023-12-20
- Completion
- 2024-05-02
- First posted
- 2022-08-26
- Last updated
- 2024-11-06
Locations
23 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05516927. Inclusion in this directory is not an endorsement.